Interferon beta-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease. Tortajada C, Anon S, Ortiz MM, Andreu-Ballester JC, et al. J Med Virol 2021 Mar 30. doi: 10.1002/jmv.26976.

Read + Share

Amedeo Smart

Independent Medical Education

Tortajada C, Anon S, Ortiz MM, Andreu-Ballester JC, et al. Interferon beta-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease. J Med Virol 2021 Mar 30. doi: 10.1002/jmv.26976.
PMID: 33856708